0,624  0,011  Antineoplastic (melanoma)
0,575  0,005  Tubulin antagonist
0,565  0,041  Antineoplastic (breast cancer)
0,526  0,004  Growth factor agonist
0,459  0,010  Cyclic AMP phosphodiesterase inhibitor
0,464  0,015  Antimitotic
0,439  0,013  Calcium channel activator
0,464  0,038  Aldehyde oxidase inhibitor
0,463  0,041  Antiasthmatic
0,436  0,021  Superoxide dismutase inhibitor
0,452  0,037  Ulceration
0,430  0,024  CYP1A2 inhibitor
0,442  0,039  Antiallergic
0,473  0,071  Caspase 9 stimulant
0,408  0,008  Pneumotoxic
0,438  0,047  Toll-Like receptor 7 agonist
0,432  0,049  Toll-Like receptor agonist
0,416  0,034  Antineoplastic (cervical cancer)
0,393  0,039  Aryl hydrocarbon receptor agonist
0,374  0,025  Antineoplastic (small cell lung cancer)
0,403  0,054  Vasodilator, peripheral
0,372  0,025  Peroxidase inhibitor
0,407  0,063  Antineoplastic (lung cancer)
0,384  0,041  Vasodilator, coronary
0,389  0,054  Prostate cancer treatment
0,392  0,066  Antileukemic
0,337  0,014  Antineoplastic (gastric cancer)
0,334  0,011  CYP2B6 inhibitor
0,358  0,035  Cardiodepressant
0,321  0,005  Age-related macular degeneration treatment
0,396  0,080  5 Hydroxytryptamine release inhibitor
0,375  0,061  Angiogenesis inhibitor
0,350  0,038  Tumour necrosis factor alpha release inhibitor
0,339  0,027  Antineoplastic (sarcoma)
0,322  0,012  Phosphodiesterase inhibitor
0,426  0,124  Antiinflammatory
0,311  0,016  Tumour necrosis factor antagonist
0,377  0,087  TNF expression inhibitor
0,310  0,021  Diabetic retinopathy treatment
0,336  0,046  Antineoplastic (non-small cell lung cancer)
0,294  0,005  Phosphodiesterase IV inhibitor
0,319  0,039  UGT1A6 substrate
0,389  0,112  Antineoplastic (solid tumors)
0,342  0,068  Antineoplastic (colorectal cancer)
0,275  0,000  Insulin like growth factor 3 antagonist
0,391  0,118  Apoptosis agonist
0,296  0,029  Non-steroidal antiinflammatory agent
0,346  0,083  CYP2C9 inhibitor
0,328  0,067  Antineoplastic (colon cancer)
0,276  0,014  Interleukin 1 antagonist
0,286  0,029  Growth factor antagonist
0,347  0,092  CYP2C19 inhibitor
0,265  0,011  Interleukin 1b antagonist
0,375  0,121  MAP kinase 1 inhibitor
0,256  0,005  Beta tubulin antagonist
0,298  0,053  Antidiabetic symptomatic
0,321  0,076  FMO1 substrate
0,303  0,060  UGT2B4 substrate
0,307  0,070  Antineoplastic (ovarian cancer)
0,303  0,070  CTGF expression inhibitor
0,257  0,025  3C-like protease (Human coronavirus) inhibitor
0,235  0,005  Protein kinase C delta inhibitor
0,290  0,061  Cardiotonic
0,291  0,064  Insulysin inhibitor
0,245  0,022  Antidiabetic (type 1)
0,231  0,008  Phosphodiesterase 4D inhibitor
0,292  0,070  Hypoxia-inducible factor 1 alpha inhibitor
0,252  0,031  Nitric-oxide synthase stimulant
0,283  0,063  Radiosensitizer
0,280  0,062  NOS2 expression inhibitor
0,272  0,055  Antineoplastic (glioblastoma multiforme)
0,238  0,024  Aldehyde oxidase substrate
0,339  0,126  Calcium channel L-type activator
0,304  0,092  Transcription factor NF kappa B inhibitor
0,243  0,032  Antineoplastic (squamous cell carcinoma)
0,278  0,067  DNA damaging
0,277  0,067  GST M1-1 substrate
0,211  0,005  Phosphodiesterase III inhibitor
0,212  0,008  Antineoplastic (uterine cancer)
0,220  0,024  UGT2B10 substrate
0,200  0,006  Alpha tubulin antagonist
0,253  0,060  Pyruvate kinase inhibitor
0,262  0,070  Antineoplastic (glioma)
0,278  0,091  Caspase 3 stimulant
0,192  0,007  Phosphodiesterase 4A inhibitor
0,219  0,038  Restenosis treatment
0,251  0,072  Cardiovascular analeptic
0,307  0,128  15-Lipoxygenase inhibitor
0,182  0,005  Acetylcholine release stimulant
0,300  0,123  Histamine release inhibitor
0,192  0,017  MAP kinase kinase 4 inhibitor
0,260  0,086  Ca(v)3.3 blocker
0,264  0,094  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,204  0,034  Allergic rhinitis treatment
0,294  0,125  Antipruritic, allergic
0,201  0,034  NADPH oxidase inhibitor
0,167  0,006  Phosphodiesterase 4C inhibitor
0,254  0,095  Antihypoxic
0,233  0,075  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,269  0,112  Cholesterol antagonist
0,198  0,043  UGT2B15 substrate
0,210  0,055  Histone acetyltransferase inhibitor
0,204  0,050  VEGF expression inhibitor
0,168  0,014  Platelet growth factor antagonist
0,165  0,013  Phosphodiesterase 3A inhibitor
0,238  0,090  Antineoplastic (bladder cancer)
0,230  0,082  Dyrk kinase inhibitor
0,327  0,178  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,240  0,091  5 Hydroxytryptamine uptake stimulant
0,221  0,073  RNA-directed DNA polymerase inhibitor
0,160  0,014  Antifungal (Pneumocystis)
0,212  0,066  Neurotrophic factor enhancer
0,234  0,089  Proliferative diseases treatment
0,229  0,088  Antipyretic
0,160  0,019  Insulin growth factor antagonist
0,211  0,072  Amyloid beta aggregation inhibitor
0,164  0,025  Platelet activating factor alpha antagonist
0,206  0,068  Insulin sensitizer
0,184  0,046  CDC-like kinase 1 inhibitor
0,300  0,163  Antidiabetic
0,300  0,163  Cyclophilin D inhibitor
0,171  0,035  Platelet activating factor antagonist
0,228  0,091  Antineoplastic (renal cancer)
0,246  0,111  12-Lipoxygenase inhibitor
0,211  0,078  Interleukin antagonist
0,209  0,077  Antineoplastic enhancer
0,159  0,028  Fibroblast growth factor 1 antagonist
0,290  0,160  Antiarthritic
0,182  0,051  Antineoplastic (carcinoma)
0,217  0,088  Antiamyloidogenic
0,141  0,014  Phosphodiesterase 4B inhibitor
0,190  0,064  LDLR expression enhancer
0,146  0,022  Alcohol dehydrogenase inhibitor
0,137  0,012  Protein kinase C alpha inhibitor
0,179  0,055  Arachidonic acid antagonist
0,202  0,080  Platelet aggregation inhibitor
0,146  0,023  DOPA decarboxylase inhibitor
0,145  0,023  Electron transport complex I inhibitor
0,180  0,059  Phobic disorders treatment
0,156  0,038  Cystathionine beta-synthase inhibitor
0,241  0,125  Antineoplastic (brain cancer)
0,127  0,012  Granulocyte macrophage colony stimulating factor agonist
0,151  0,035  GST P1-1 substrate
0,229  0,114  Lipoxygenase inhibitor
0,170  0,056  Cyclooxygenase inhibitor
0,119  0,007  Potassium channel (Ca-activated) blocker
0,150  0,037  Microtubule formation inhibitor
0,218  0,107  UGT1A9 substrate
0,179  0,069  Succinate dehydrogenase inhibitor
0,156  0,048  Toll-Like receptor 2 antagonist
0,190  0,082  5 Hydroxytryptamine 3E antagonist
0,142  0,039  Interleukin 8 antagonist
0,160  0,056  Mannose-6-phosphate isomerase inhibitor
0,196  0,093  VCAM1 expression inhibitor
0,164  0,063  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,144  0,043  Gastritis treatment
0,132  0,031  Uric acid excretion stimulant
0,132  0,032  Breast cancer-resistant protein inhibitor
0,184  0,085  I kappa B kinase epsilon inhibitor
0,244  0,145  Inflammatory Bowel disease treatment
0,106  0,010  Phosphodiesterase 3B inhibitor
0,196  0,101  Free radical scavenger
0,157  0,062  Activin receptor-like kinase 2 inhibitor
0,128  0,035  HIV-1 integrase (Overall Integration) inhibitor
0,149  0,055  Pregnane X receptor agonist
0,134  0,042  Protein kinase C gamma inhibitor
0,211  0,119  Antineoplastic (pancreatic cancer)
0,174  0,085  P-glycoprotein inhibitor
0,158  0,072  Neuropathy treatment
0,202  0,116  Chronic obstructive pulmonary disease treatment
0,160  0,075  UGT1A3 substrate
0,090  0,007  Estrogen-related receptor alpha antagonist
0,227  0,144  ICAM1 expression inhibitor
0,135  0,052  Beta amyloid protein antagonist
0,202  0,119  5 Hydroxytryptamine release stimulant
0,149  0,066  Lck kinase inhibitor
0,222  0,140  AR expression inhibitor
0,152  0,071  GABA C receptor rho-2 antagonist
0,103  0,023  Fibroblast growth factor 2 antagonist
0,138  0,059  Antihyperlipoproteinemic
0,109  0,031  Glutamate release inhibitor
0,108  0,030  Ankylosing spondylitis treatment
0,088  0,011  Protein kinase C theta inhibitor
0,185  0,108  Antineoplastic (lymphoma)
0,119  0,043  Obsessive-compulsive disorder treatment
0,112  0,036  Toll-Like receptor 3 antagonist
0,187  0,113  Antihypercholesterolemic
0,150  0,076  Antimutagenic
0,166  0,094  Antieczematic atopic
0,235  0,163  CYP2C9 substrate
0,141  0,070  Cytokine production inhibitor
0,203  0,132  Antidiabetic (type 2)
0,148  0,080  CF transmembrane conductance regulator agonist
0,115  0,048  Bronchodilator
0,150  0,082  Carcinogenic, group 1
0,134  0,067  Cyclooxygenase 2 inhibitor
0,242  0,174  Analgesic, non-opioid
0,193  0,126  Antiprotozoal (Trypanosoma)
0,189  0,123  Antioxidant
0,133  0,068  Cyclooxygenase 1 inhibitor
0,113  0,049  Gastric antisecretory
0,117  0,054  Gout treatment
0,112  0,050  Dementia treatment
0,149  0,087  Heat shock protein 90 alpha antagonist
0,145  0,083  UGT2B9 substrate
0,164  0,103  UGT1A1 substrate
0,162  0,100  Septic shock treatment
0,114  0,053  Antiprotozoal (Toxoplasma)
0,210  0,150  FMO3 substrate
0,147  0,086  Melanin inhibitor
0,153  0,094  Neurotensin receptor agonist
0,178  0,118  Antineoplastic (lymphocytic leukemia)
0,088  0,029  Raf kinase C inhibitor
0,138  0,079  SULT1A3 substrate
0,104  0,045  Calcium antagonist
0,083  0,024  Glutamate (mGluR7) antagonist
0,107  0,049  UGT2B11 substrate
0,107  0,050  Vascular dementia treatment
0,077  0,020  Transcription factor RelA inhibitor
0,185  0,128  Antihypotensive
0,102  0,046  SULT1E1 substrate
0,066  0,009  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,068  0,014  Alpha 1L adrenoreceptor antagonist
0,163  0,110  Focal adhesion kinase 2 inhibitor
0,211  0,159  CYP3A4 inhibitor
0,166  0,114  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,106  0,055  Xanthine oxidase inhibitor
0,086  0,036  Cushing's syndrome treatment
0,067  0,017  Phosphodiesterase X inhibitor
0,067  0,017  Phosphodiesterase 10A inhibitor
0,135  0,086  Genotoxic
0,114  0,065  Photosensitizer
0,137  0,089  Heat shock protein 90 antagonist
0,125  0,078  Amylase inhibitor
0,083  0,036  MAP kinase 7 inhibitor
0,140  0,094  UGT1A4 substrate
0,156  0,110  Antiarrhythmic
0,088  0,042  CYP2A6 inhibitor
0,107  0,062  UGT2B1 substrate
0,199  0,156  CYP1A2 substrate
0,189  0,147  Chemoprotective
0,159  0,118  Antihypertriglyceridemic
0,115  0,073  Retinopathy treatment
0,113  0,072  Antiprotozoal (Babesia)
0,181  0,140  Radioprotector
0,213  0,172  GST A substrate
0,070  0,029  Corticotropin releasing factor 2 receptor antagonist
0,140  0,099  Macular degeneration treatment
0,074  0,034  Exportin-1 inhibitor
0,049  0,009  Vanilloid 3 antagonist
0,186  0,149  CYP2C19 substrate
0,120  0,085  Toll-Like receptor antagonist
0,130  0,096  Chemopreventive
0,135  0,102  Aldose reductase substrate
0,205  0,171  Antithrombotic
0,076  0,044  S-adenosyl-L-methionine decarboxylase inhibitor
0,078  0,046  Lipase inhibitor
0,104  0,073  Monophenol monooxygenase inhibitor
0,049  0,019  Urate transporter 1 inhibitor
0,139  0,109  LIM domain kinase 1 inhibitor
0,079  0,049  Keratolytic
0,135  0,105  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,132  0,102  Hexokinase inhibitor
0,092  0,062  Protein kinase C zeta inhibitor
0,089  0,060  Phosphodiesterase I inhibitor
0,133  0,105  Interferon gamma antagonist
0,064  0,038  Phosphodiesterase 1C inhibitor
0,138  0,113  Cytotoxic
0,115  0,090  Antibacterial (Helicobacter pylori)
0,117  0,092  Antiprotozoal (Trichomonas)
0,049  0,025  Estradiol 17 beta-dehydrogenase inhibitor
0,055  0,030  Glucose-6-phosphate translocase inhibitor
0,088  0,065  Paget's disease treatment
0,157  0,134  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,086  0,064  Antidote, mercury
0,081  0,060  5 Hydroxytryptamine 2C antagonist
0,034  0,013  Nicotinic alpha4beta2 receptor agonist
0,056  0,035  Prostaglandin antagonist
0,076  0,055  Fibroblast growth factor 3 antagonist
0,037  0,017  Melatonin receptor 1A agonist
0,031  0,011  Prostaglandin D2 antagonist
0,123  0,104  Antiprotozoal (Coccidial)
0,077  0,058  Antidote, organophosphates
0,086  0,067  Proto-oncogene tyrosine-protein kinase Kit inhibitor
0,093  0,075  Glutamate (mGluR7) agonist
0,212  0,193  GABA C receptor rho-3 antagonist
0,092  0,074  Sulfotransferase substrate
0,046  0,029  Potassium channel small-conductance Ca-activated blocker
0,097  0,079  Antihelmintic (Fasciola)
0,067  0,050  Endocannabinoid uptake inhibitor
0,069  0,052  Histidine decarboxylase inhibitor
0,131  0,114  Antipruritic, non-allergic
0,180  0,164  Antiviral (West Nile virus)
0,131  0,115  Heat shock protein 70 antagonist
0,055  0,040  5 Hydroxytryptamine 7 agonist
0,139  0,124  Clk dual-specificity kinase inhibitor
0,089  0,074  Vascular endothelial growth factor 1 antagonist
0,058  0,043  Aromatase inhibitor
0,138  0,124  ATPase inhibitor
0,116  0,102  Nav1.6 sodium channel blocker
0,097  0,083  SULT1A1 substrate
0,064  0,051  Acetylcholine M5 receptor agonist
0,027  0,013  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,052  0,040  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,062  0,050  Calcium channel P-type blocker
0,030  0,018  Thiazolidinedione
0,057  0,046  Ryanodine receptor antagonist
0,058  0,046  Cyclin D1 inhibitor
0,028  0,017  Hedgehog signaling activator
0,077  0,066  Carcinogenic, group 2A
0,080  0,069  D-Ala-D-Ala ligase inhibitor
0,066  0,056  Benzodiazepine agonist
0,107  0,098  Coagulant
0,108  0,100  Sodium channel (voltage-gated) blocker
0,090  0,083  Antifungal (Candida)
0,026  0,019  Kynurenine 3 monooxygenase inhibitor
0,015  0,010  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,062  0,057  Potassium channel (ATP-sensitive) blocker
0,050  0,046  Xanthine dehydrogenase inhibitor
0,110  0,106  Vascular endothelial growth factor 3 antagonist
0,017  0,013  CC chemokine 9 receptor antagonist
0,047  0,044  Aconitate hydratase inhibitor
0,100  0,097  Aldehyde dehydrogenase inhibitor
0,106  0,103  Toll-Like receptor 9 antagonist
0,108  0,105  Antihelmintic (Trematoda)
0,084  0,081  Sphingomyelinase inhibitor
0,057  0,054  Purinergic P2X2 antagonist
0,090  0,088  Choleretic
0,080  0,078  ATPase (Vacuolar H+) inhibitor
0,096  0,093  Nav1.5 sodium channel blocker
0,040  0,038  Oleamide hydrolase inhibitor
0,169  0,167  5 Hydroxytryptamine 1E antagonist
0,067  0,066  Orexin receptor 1 antagonist

